Journal of Medicinal Chemistry · 2012 · 56 citations · 64 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryEnzymologyMolecular PharmacologyDrug-metabolizing EnzymesEnzyme InhibitionMolecular Docking AnalysisProtein Mass Spectrometry
Sulfonyl fluorides are known to inhibit esterases. Early work from our laboratory has identified hexadecyl sulfonylfluoride (AM374) as a potent in vitro and in vivo inhibitor of fatty acid amide hydrolase (FAAH). We now report on later generation sulfonyl fluoride analogs that exhibit potent and selective inhibition of FAAH. Using recombinant rat and human FAAH, we show that 5-(4-hydroxyphenyl)pentanesulfonyl fluoride (AM3506) has similar inhibitory activity for both the rat and the human enzyme, while rapid dilution assays and mass spectrometry analysis suggest that the compound is a covalent modifier for FAAH and inhibits its action in an irreversible manner. Our SAR results are highlighted by molecular docking of key analogs.
64
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
William A. Devane, Aviva Breuer, Roger G. Pertwee et al. · Science · 1992 · 5.6K citations
Determination and characterization of a cannabinoid receptor in rat brain.
William A. Devane, F A Dysarz, M R Johnson et al. · Molecular Pharmacology · 1988 · 2.4K citations
Medicine, Neuroscience, Pharmacology +12
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Benjamin F. Cravatt, Dan K. Giang, Stephen P. Mayfield et al. · Nature · 1996 · 2.1K citations
Benjamin F. Cravatt, Kristin Demarest, Matthew P. Patricelli et al. · Proceedings of the National Academy of Sciences · 2001 · 1.3K citations · Full text
Medicine, Neuroscience, Pharmacology +13
Modulation of anxiety through blockade of anandamide hydrolysis
Satish Kathuria, Silvana Gaetani, Darren Fegley et al. · Nature Medicine · 2002 · 1.3K citations · Full text
Medicine, Neuroscience, Pharmacology +12